{
    "name": "spinosad",
    "comment": "Rx",
    "other_names": [
        "Natroba"
    ],
    "classes": [
        "Scabicidal Agents"
    ],
    "source": "https://reference.medscape.com/drug/natroba-spinosad-999619",
    "pregnancy": {
        "common": [
            "Active ingredient (spinosad) is not absorbed systemically following topical application, and maternal use is not expected to result in fetal drug exposure ",
            "Contains benzyl alcohol; topical benzyl alcohol is unlikely to be absorbed through the skin in clinically relevant amounts; therefore, maternal use is not expected to result in fetal drug exposure "
        ],
        "specific": [
            {
                "type": "Animal data",
                "description": [
                    "No adverse embryofetal effects were seen at oral doses of spinosad up to 200 mg/kg/day in pregnant rats or 50 mg/kg/day in pregnant rabbits administered during organogenesis "
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "Active ingredient (spinosad) is not distributed in breast milk; however, caution advised because the benzyl alcohol component may be systemically absorbed; lactating women may choose to pump and discard breast milk for 8 hr (5 half-lives of benzyl alcohol) following application"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Inform healthcare practitioner of any skin conditions or sensitivities",
                "Contains benzyl alcohol; toxicity and deaths reported in neonates and infants below the age of 6 months with systemic exposure to benzyl alcohol (ie, neonatal gasping syndrome)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Application site erythema",
            "percent": "3"
        },
        {
            "name": "Ocular erythema",
            "percent": "2"
        },
        {
            "name": "Ocular hyperemia",
            "percent": "2"
        },
        {
            "name": "Application site irritation",
            "percent": "1"
        },
        {
            "name": "Application site dryness",
            "percent": null
        },
        {
            "name": "Application site exfoliation",
            "percent": null
        },
        {
            "name": "Alopecia",
            "percent": null
        },
        {
            "name": "Dry skin",
            "percent": null
        }
    ]
}